STOCK TITAN

Cue Health Inc - HLTH STOCK NEWS

Welcome to our dedicated news page for Cue Health (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cue Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cue Health's position in the market.

Rhea-AI Summary
Tarsadia Investments calls on Cue Health board to take immediate action to prevent further destruction of stockholder value. They criticize Cue's flawed capital allocation and unsustainable cost structure. Urgent change is needed to address declining cash balance and destruction of stockholder value. Cue's stockholders have experienced a -97% decline in share price from IPO. Quarterly product revenues declined -97% from $223 million in Q3 2021 to $8 million in the past quarter. Cue may run out of cash and be required to raise $75 million in new equity, resulting in over 50% dilution to existing shareholders. Tarsadia submits Section 220 request to inspect company's books and records.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.45%
Tags
none
-
Rhea-AI Summary
Cue Health to present at investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.46%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
Rhea-AI Summary
Cue Health awarded $28 million contract to develop multiplex test for flu, RSV, and COVID-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.6%
Tags
covid-19
-
Rhea-AI Summary
Cue Health Inc. (Nasdaq: HLTH) will release its second quarter 2023 financial results on August 9, 2023. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results and recent highlights. Participants can access the live call via telephone or the company's website. A replay of the webinar will be available on the website after the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.86%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.17%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.07%
Tags
-
Rhea-AI Summary
Cue Health has submitted a De Novo application to the FDA for full clearance of the Cue RSV Molecular Test for at-home and point-of-care use. The test, if approved, would be the first at-home molecular RSV test on the market. RSV is a common respiratory virus that can be severe, especially for infants and older adults. Cue's test uses a lower nasal swab and provides results in approximately 25 minutes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.14%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.95%
Tags
none
Cue Health Inc

Nasdaq:HLTH

HLTH Rankings

HLTH Stock Data

25.77M
97.10M
12.83%
47.89%
0.36%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
San Diego

About HLTH

cue, a revolutionary device for tracking health information at the molecular level. for the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin d, fertility, influenza, and testosterone in just minutes, at home. cue sends the data via bluetooth 4.0 to the user's smartphone, where the free cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level. by simply adding a noninvasive droplet of saliva, blood, or nasal swab, you can access deep information about your body only previously available from a lab -- on demand and on your schedule. interactive charts put you in touch with your health, making it easy to discover new trends, monitor your progress, and share it with the people who matter most. cue also features life feed, an incredible new smartphone-based way to visualize the daily effect of activity, food, and sleep on your molecular health. cue makes research-based recommendations for foods proven to sup